Dupilumab in Children and Adolescents with Severe Atopic Dermatitis and Severe Asthma: A Case Series

Dupilumab in Children and Adolescents with Severe Atopic Dermatitis and Severe Asthma: A Case Series

The increasing incidence and common specific inflammatory type 2 intracellular pathways have recently allowed for the rise of new biologic therapies in two inflammatory chronic diseases in children: atopic dermatitis (AD) and severe asthma. Such therapies aim at relieving symptoms and reducing infla...

Full description

Bibliographic Details
Main Authors: Daniele Russo, Giulia Michela Pellegrino, Paola Di Filippo, Teresa Ruggiero, Sabrina Di Pillo, Francesco Chiarelli, Giuseppe Francesco Sferrazza Papa, Marina Attanasi
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Applied Sciences
Subjects:
atopic dermatitis
severe asthma
endotypes
dupilumab
sleep
quality of life
Online Access:https://www.mdpi.com/2076-3417/13/19/10902

Internet

https://www.mdpi.com/2076-3417/13/19/10902

Similar Items